Home
|
Contact Us
|
Careers
Clinical Trials
Business
Investor Center
Most Recent 10-K, Annual Meeting Notice and Proxy Statement
Board of Directors
Management Team
Corporate Governance
News Archive
Careers
SEC Filings
Science
Therapeutic Pathways
ENMD-2076 for Oncology
2ME2 (2-methoxyestradiol)
MKC-1
Science Archive
Science
Therapeutic Pathways
ENMD-2076 for Oncology
2ME2 (2-methoxyestradiol)
MKC-1
Science Archive
Science Archive
Browse EntreMed’s scientific posters, presentations and publications.
Friday, June 3, 2011 -
EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients
ENMD-2076 in Platinum Resistant Ovarian Cancer
,
Read the press release
Tuesday, December 7, 2010 -
Data for ENMD-2076 Phase 1 Studies in Multiple Myeloma and Leukemia Presented at ASH
ENMD-2076 Leukemia
ENMD-2076 Multiple Myeloma
,
Read the press release
Monday, November 16, 2009 -
EntreMed’s ENMD-2076 Active in Solid and Hematological Cancers
Download the poster
,
Read the press release
Tuesday, June 9, 2009 -
ASCO Poster Presentations
ENMD-2076 poster
MKC-1 poster
ENMD-1198 poster
,
Read the press release
Monday, June 1, 2009 -
EntreMed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
Download the poster
Download the slides
,
Read the press release
Monday, February 9, 2009 -
EntreMed Presents Initial Clinical Results for ENMD-2076
View the poster
,
Read the press release
Tuesday, December 9, 2008 -
EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
View the poster
,
Read the press release
Thursday, October 23, 2008 -
EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
View the presentation
,
Read the press release
Tuesday, June 3, 2008 -
EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
View the poster
,
Read the press release
Wednesday, April 16, 2008 -
EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
View the posters
,
Read the press release